1. Treatment with low-dose tacrolimus inhibits bleeding complications in a patient with hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension. (November 2018) Authors: Sommer, N; Droege, F; Gamen, KE; Geisthoff, U; Gall, H; Tello, K; Richter, MJ; Deubner, LM; Schmiedel, R; Hecker, M; Spiekerkoetter, E; Wirsching, K; Seeger, W; Ghofrani, HA; Pullamsetti, S Journal: Pulmonary circulation Issue: Volume 9:Number 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Treatment with low‐dose tacrolimus inhibits bleeding complications in a patient with hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension. (1st November 2018) Authors: Sommer, N; Droege, F; Gamen, KE; Geisthoff, U; Gall, H; Tello, K; Richter, MJ; Deubner, LM; Schmiedel, R; Hecker, M; Spiekerkoetter, E; Wirsching, K; Seeger, W; Ghofrani, HA; Pullamsetti, S Journal: Pulmonary circulation Issue: Volume 9:Number 2(2019) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗